Exploration of urine metabolic biomarkers for new-onset, untreated pediatric epilepsy: A gas and liquid chromatography mass spectrometry-based metabolomics study.
Tomoyuki AkiyamaDaisuke SaigusaTakushi InoueChiho TokorodaniMari AkiyamaRie MichiueAtsushi MoriEiji HishinumaNaomi MatsukawaTakashi ShibataHiroki TsuchiyaKatsuhiro KobayashiPublished in: Brain & development (2024)
Urine metabolome analysis, which covers a larger number of metabolites than conventional biochemistry analyses, found no consistently altered small molecule metabolites except for reduced taurine in epilepsy patients compared to healthy controls. Further studies with larger samples, subjects with different ages, expanded target metabolites, and the investigation of plasma samples are required.
Keyphrases
- mass spectrometry
- liquid chromatography
- small molecule
- ms ms
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- high resolution mass spectrometry
- tandem mass spectrometry
- high resolution
- high performance liquid chromatography
- capillary electrophoresis
- prognostic factors
- patient reported outcomes
- peritoneal dialysis
- protein protein
- simultaneous determination
- young adults
- temporal lobe epilepsy
- ionic liquid